Group B Streptococcus Gbs Disease clinical trials

Explore recruiting group b streptococcus gbs disease clinical trials.

Also recruiting in Europe

Group B Streptococcus Gbs Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

C1091009 - A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT GROUP B STREPTOCOCCUS VACCINE IN HEALTHY PREGNANT WOMEN AND THEIR INFANTS

Finland, Netherlands, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Group B Streptococcus Gbs Disease trials by city

Group B Streptococcus Gbs Disease in Toronto Group B Streptococcus Gbs Disease in Vancouver Group B Streptococcus Gbs Disease in Montreal Group B Streptococcus Gbs Disease in Calgary Group B Streptococcus Gbs Disease in Edmonton Group B Streptococcus Gbs Disease in Ottawa Group B Streptococcus Gbs Disease in Winnipeg Group B Streptococcus Gbs Disease in Quebec City Group B Streptococcus Gbs Disease in Hamilton Group B Streptococcus Gbs Disease in Kitchener Group B Streptococcus Gbs Disease in London Group B Streptococcus Gbs Disease in Halifax Group B Streptococcus Gbs Disease in New York Group B Streptococcus Gbs Disease in Los Angeles Group B Streptococcus Gbs Disease in Chicago Group B Streptococcus Gbs Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease